Mesenchymal stromal cell-derived exosomes in cardiac regeneration and repair.

Stem Cell Reports
Si-Jia SunHung-Fat Tse

Abstract

Mesenchymal stromal cell (MSC)-derived exosomes play a promising role in regenerative medicine. Their trophic and immunomodulatory potential has made them a promising candidate for cardiac regeneration and repair. Numerous studies have demonstrated that MSC-derived exosomes can replicate the anti-inflammatory, anti-apoptotic, and pro-angiogenic and anti-fibrotic effects of their parent cells and are considered a substitute for cell-based therapies. In addition, their lower tumorigenic risk, superior immune tolerance, and superior stability compared with their parent stem cells make them an attractive option in regenerative medicine. The therapeutic effects of MSC-derived exosomes have consequently been evaluated for application in cardiac regeneration and repair. In this review, we summarize the potential mechanisms and therapeutic effects of MSC-derived exosomes in cardiac regeneration and repair and provide evidence to support their clinical application.

References

Sep 1, 1991·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·A I Caplan
Sep 6, 2005·Blood·Anna CorcioneAntonio Uccelli
Aug 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alma J NautaWillem E Fibbe
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Eva van RooijEric N Olson
Sep 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yajaira SuárezWilliam C Sessa
Mar 12, 2010·Expert Opinion on Biological Therapy·Wesley M JacksonRocky S Tuan
Oct 19, 2011·Journal of Cellular and Molecular Medicine·Zhuzhi WenTong Wang
Mar 1, 2012·Seminars in Cardiothoracic and Vascular Anesthesia·Anja FrankTobias Eckle
Mar 20, 2012·The Journal of Clinical Investigation·Arin B AuroraEric N Olson
Apr 26, 2012·Nature Reviews. Immunology·Katarina Le Blanc, Dimitrios Mougiakakos
Dec 1, 2012·Stem Cells Translational Medicine·Guangwen RenYufang Shi
Dec 29, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Laura S DanielsonEva Hernando
Aug 2, 2013·Journal of Cellular Biochemistry·Guangwei LvShimin Dong
Dec 18, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Suyan BianHepeng Yu
Dec 26, 2013·Stem Cells and Development·Bin ZhangSai Kiang Lim
Jan 18, 2014·Circulation Research·Xavier LoyerChantal M Boulanger
Mar 20, 2014·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Stéphano F S MeloEdilamar M Oliveira
Aug 20, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D M PegtelS Amor
Apr 23, 2015·Journal of the American Society of Nephrology : JASN·Federica CollinoGiovanni Camussi
Jan 5, 2016·Journal of Extracellular Vesicles·Thomas LenerBernd Giebel

❮ Previous
Next ❯

Citations

Jul 25, 2021·International Journal of Molecular Sciences·Fernanda GubertGisele Zapata-Sudo
Sep 8, 2021·Nature Metabolism·Joo Hyun Park, Jan-Wilhelm Kornfeld

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.